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Statement of significance: We found no evidence for a clinically relevant ability of QST to predict 
the transition from acute to chronic low back pain. This indicates that assessment of central 
hypersensitivity using currently available quantitative sensory tests is unlikely to identify patients at 
risk and therefore unlikely to inform clinical decision making.  
 
ABSTRACT 
Background: It would be desirable to identify patients with acute low back pain who are at high risk 
for transition to chronic pain early in the course of their disease. This would enable early preventive 
or therapeutic interventions. Patients with chronic low back pain (CLBP) display signs of central 
hypersensitivity. This may contribute to the transition to CLBP. We tested the hypothesis that central 
hypersensitivity as assessed by quantitative sensory tests predicts transition to CLBP. 
 
Methods: We performed a prospective cohort study in 130 patients with acute low back pain 
recruited in a primary care setting to determine the ability of 14 tests using electrical, pressure and 
temperature stimulation to predict transition to CLBP after six months. We assessed the association of 
tests with transition to CLBP in multivariable analyses adjusted for socio-demographic, psychological 
and clinical characteristics, quantified the performance of tests using receiver operating characteristics 
(ROC) curves, and calculated likelihood ratios for different cut-off values for most promising tests.  
 
Results: None of the evaluated tests showed a statistically significant or clinically relevant ability to 
predict the transition to CLBP, with 95% CI of crude and adjusted associations of all tests including 
one as measure of no association. Corresponding estimates of areas under the ROC curves were below 
0.5 and none of the 95% CI crossed the pre-specified boundary of clinical relevance set at 0.70.  
 
Conclusions: We found no evidence to support a clinically relevant ability of current quantitative 
sensory tests to predict the transition from acute to CLBP. 
 
Keywords: Chronic low back pain, Prognosis, Central hypersensitivity, Quantitative Sensory Tests. 
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INTRODUCTION  
Low back pain is one of the leading causes of years lived with disability (Murray et al., 2015). The 
life-time prevalence is 70-85% (Andersson, 1999) and the estimated point prevalence is 10-30% 
(Freemont et al., 1997; Andersson, 1999; Hoy et al., 2012; Hoy et al., 2014). Low back pain is one of 
the most frequent reasons for doctor visits (Hart et al., 1995; Deyo et al., 2006) and has a high socio-
economic burden (Maniadakis and Gray, 2000; Ekman et al., 2005; Dagenais et al., 2008). 10-20% of 
patients experience recurrent episodes or a chronic course (Andersson, 1999; Hestbaek et al., 2003; 
Henschke et al., 2008; Chou and Shekelle, 2010; Hasenbring et al., 2012). It would therefore be 
desirable to identify patients at risk for transition to chronic low back pain (CLBP) early, as this may 
enable early preventive or therapeutic interventions.  
There is evidence for the role of socio-demographic, psychological and clinical characteristics 
for the transition to CLBP (Dionne et al., 1997; Schiottz-Christensen et al., 1999; Linton, 2000; 
Picavet et al., 2002; Pincus et al., 2002; Coste et al., 2004; Dunn et al., 2006; Jones et al., 2006; 
Swinkels-Meewisse et al., 2006; Foster et al., 2008; Chou and Shekelle, 2010; Dunn et al., 2011; 
Campbell et al., 2013). Significant factors include work-related factors (Dionne et al., 1997; Schiottz-
Christensen et al., 1999; Dunn et al., 2006; Jones et al., 2006; Dunn et al., 2011; Campbell et al., 
2013); catastrophizing, expectation of poor treatment outcome and fear-avoidance (Dionne et al., 
1997; Picavet et al., 2002; Dunn et al., 2006; Jones et al., 2006; Swinkels-Meewisse et al., 2006; 
Foster et al., 2008; Campbell et al., 2013); depression and anxiety (Dionne et al., 1997; Dunn et al., 
2006; Dunn et al., 2011; Campbell et al., 2013); and high pain intensity or disability at baseline 
(Dionne et al., 1997; Schiottz-Christensen et al., 1999; Dunn et al., 2006; Swinkels-Meewisse et al., 
2006; Dunn et al., 2011; Campbell et al., 2013). However, systematic reviews were inconclusive as to 
the clinical importance of these risk factors (Linton, 2000; Pincus et al., 2002; Hestbaek et al., 2003; 
Chou and Shekelle, 2010).  
Knowledge on the importance of central hypersensitivity led to an increasing application of 
quantitative sensory test (Birklein and Sommer, 2013) and was proposed to contribute for the 
transition to CLBP (Giesecke et al., 2004; O'Neill et al., 2007; Blumenstiel et al., 2011; Neziri et al., 
2012; Puta et al., 2013). There is overwhelming pre-clinical evidence that acute injuries cause 
neuroplastic changes that lead to hypersensitivity (Woolf and Salter, 2000), and that hypersensitivity 
is potentially involved in the transition to chronic pain (Arendt-Nielsen et al., 2018). Noticeably, 
hypersensitivity has been detected in acute low back pain (ALBP) (Vuilleumier et al., 2017). 
Furthermore, previous case-control studies found that pain thresholds after painful stimuli at non-
painful sites were lower in patients with CLBP as compared to pain-free controls. All but one study 
included a small number of participants, which made multivariable analysis adjusting for the above 
mentioned risk factors difficult (Giesecke et al., 2004; O'Neill et al., 2007; Blumenstiel et al., 2011; 
Puta et al., 2013). The largest case-control study evaluated the discriminative ability of 26 quantitative 
A
cc
ep
te
d
 A
rt
ic
le
This article is protected by copyright. All rights reserved. 
sensory tests in distinguishing between patients and pain-free controls (Neziri et al., 2012). Pressure 
and electrical stimulation modalities ranked first, with areas under the receiver operating curves 
(ROC) of 0.80 (Neziri et al., 2012). Case-control studies are limited by their cross-sectional nature 
and arbitrary spectrum of cases and controls, and can therefore not determine the ability of different 
tests to predict transition to CLBP. LeResche et al published the first prospective cohort in 147 
primary care patients with ALBP and found none of five tests examined to be associated with 
transition to CLBP (LeResche et al., 2013). However, the study included highly selected patients, 
since only about 10% of those initially considered were analyzed. Moreover, a limited number of tests 
was employed and the study did not evaluate ROCs. 
We performed a large prospective cohort study in a representative sample of primary care 
patients with ALBP, using an extensive protocol of 14 tests evaluating six modalities. The hypothesis 
was that more pathological test values, pointing to hypersensitivity in early stages of low back pain, 
predict CLBP after six months. We expected that low thresholds after pressure, electrical and heat 
stimulation, high thresholds after cold stimulation, short hand withdrawal time of the cold pressor test 
and impaired conditioned pain modulation were associated with an increased risk of transition to 
CLBP. 
 
METHODS 
Study population 
We recruited patients with acute low back pain at a primary care group practice in Bern, Switzerland.  
We included patients suffering from low back pain with a pain intensity of at least 3 on a numerical 
rating scale (NRS, 0 = “no pain” and 10 = “worst pain imaginable”), at any day during the week 
preceding recruitment. We defined acute low back pain as predominant lumbar back pain with or 
without radiation to the leg, with a maximal duration of six weeks and no more than three pain 
episodes during the preceding year. Before inclusion into the study, all patients underwent physical 
examination by their referring general practitioner. At study inclusion, all patients underwent a repeat 
physical examination by the study staff to identify any sensory or motor deficit of the lower extremity.  
We excluded patients with acute lumbosacral radiculopathy defined as pain with dermatome-
associated distribution, with or without neurological signs of spinal nerve compression such as 
dermatome-associated sensory loss, impaired motor function or attenuated reflexes. In case of 
suspected acute lumbosacral radiculopathy, patients would also receive a magnet resonance image 
(MRI) in accordance with clinical guidelines (Chou et al., 2007). None of the patients included in the 
present study had to receive an MRI. Other reasons of exclusion were back pain caused by accident, 
history of back surgery, rheumatologic inflammatory disease, neurological co-morbidity potentially 
affecting the neurological function of the lower extremity to be tested, and psychiatric co-morbidity 
except unipolar depressive disorder. We also excluded patients unable to understand the consequences 
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of study participation due to language problems and patients who could not be contacted by phone or 
mail after initial consultation with their general practitioner. Four assessors performed all study-
related procedures at the Department of Anesthesiology and Pain Medicine of the University Hospital 
of Bern, including eligibility screening, baseline and follow-up assessment according to a 
standardized, prospective protocol. The protocol was approved by the local research ethics committee 
(study no. 103/08) and conducted in accordance with the Declaration of the World Medical 
Association (Worlds, 2008). All patients gave written informed consent. 
   
Quantitative Sensory Tests 
We performed QST according to a previously applied prospective protocol (Neziri et al., 2012) in a 
quiet room of our QST laboratory to avoid distraction of the patients. Participants were lying in a bed 
with a leg rest placed under the knees to obtain a 30° semi-flexion for electrophysiological testing. All 
patients received identical and clear instruction regarding the testing session and underwent a training 
session to familiarize themselves with the stimulation procedure before data collection was initiated. 
This is considered essential before formal testing is started and thus is common practice of testing 
protocols (Neziri et al., 2012; Backonja et al., 2013). We performed QST at the extremity 
contralateral to the most painful area of low back pain, the most painful area at the lower back and at a 
non-painful site of the back. In case of bilateral back pain, the testing extremity was randomly 
selected according to a computer-generated list. We made two measurements and considered the 
mean value for data analysis, except for the cold pressor test and the assessment of conditioned pain 
modulation, for which only one measurement was taken. We randomly assigned the sequence of 
testing modalities according to a computer-generated list to avoid  bias as a result of testing order 
(Grone et al., 2012). Mechanisms investigated were stimulus-specific pain hypersensitivity (pain 
detection and pain tolerance threshold to different stimulus modalities), tissue-specific pain 
hypersensitivity (thresholds to skin and muscle stimulation), localized and widespread pain 
hypersensitivity (stimulation at the areas of pain and at distant areas), temporal summation (induction 
of short-lasting central hyper-excitability by repeated stimulation) and endogenous pain inhibition 
(conditioned pain modulation, CPM). Stimulation sites at the area of pain were expected to reflect 
sensitivity of neural structures corresponding to the site of a potential primary nociceptive input 
(regional sensitization), whereas stimulation at areas distant from the site of pain were expected to 
reflect widespread sensitization of neural structures. 
We pre-specified pressure pain tolerance threshold at the second toe as our primary prognostic 
variable. We assessed pain detection and pain tolerance thresholds using an electronic pressure 
algometer with a 1 cm
2
 surface probe (Somedic, Hörby, Sweden) (Brennum et al., 1989). We 
performed the pressure tests at the center of the pulp of the 2
nd
 toe contralateral to the side of most 
pain, the site of most pain at the back and a non-painful site at the back. Pressure was increased from 
0 at a rate of 30 kPa/s to a maximum of 1000 kPa. We defined pain detection threshold as the point at 
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which the pressure sensation turned into pain and pain tolerance threshold as the point at which the 
subject felt the pain as intolerable. The participants had to press a button when these points were 
reached and the algometer displayed the corresponding pressure intensity. In case that a participant 
did not press the button below 1000 kPa, this value was considered as threshold.  
We performed electrical stimulation using bipolar surface Ag/AgCl-electrodes placed distal to 
the lateral malleolus contralateral to the side of most pain, which corresponds to the innervation area 
of the sural nerve. A computer-controlled constant current stimulator (NCS System, Evidence 3102 
evo, Neurosoft, Russia) delivered a train-of-five 1 ms square-wave pulses of an overall duration of 25 
ms. This train-of-five is perceived as a single stimulus by the patients. In a single increasing intensity 
staircase, the current intensity was increased from 1 mA in steps of 1 mA, until the electrical stimulus 
was perceived as painful (pain detection threshold) and until a nociceptive withdrawal reflex (NWR) 
of the biceps femoris with an amplitude higher than 20µV for at least 10ms in the 50 to 150ms post-
estimation interval was elicited (reflex detection threshold) (Willer, 1977; Willer, 1984; Rhudy and 
France, 2011). Temporal summation occurs when repetition of a stimulus increases pain perception, 
likely due to short-lasting spinal cord sensitization. To elicit temporal summation, we repeated the 
train-of-five stimulus five times with a frequency of 2 Hz at a constant intensity (Arendt-Nielsen et 
al., 1994). As pre-specified by our protocol, the first 40 patients included in the study were randomly 
assigned in a 1:1 ratio to either undergo electrical stimulation with assessment of pain and reflex 
detection threshold, or assessment of EEG activity as response to painful stimulation. Therefore, data 
on pain detection threshold after single and repeated electrical stimulation were missing in 18 patients 
and were considered to be missing completely at random. Results of the EEG assessment have been 
reported in a separate paper (Vuilleumier et al., 2017). 
We used a thermode with a surface of 30 x 30 mm to assess pain sensitivity to heat and cold 
(TSA-II; Medic, Ramat Yishai, Israel). The tests were performed at the lateral aspect of the leg, 
midway between the knee and the lateral malleolus and the lateral aspect of the arm, midway between 
the elbow and the wrist. The temperature of the thermode was increased at a rate of 0.5 ºC/sec from 
30 ºC to a maximum of 50.5 ºC and to a minimum of 0°C until the stimulus was perceived as painful; 
at this point, the participants pressed the button and the temperature went back to baseline. Threshold 
values were truncated in case of participants who did not report pain at the maximum of 50.5°C or the 
minimum of 0.0°C, respectively.  
We assessed the response to a tonic cold painful stimulus with the cold pressor test. The hand 
was immersed in ice saturated water (1.5 1°C) for a duration of two minutes. The device consisted of 
a container separated into an outer and an inner part by a mesh screen. The mesh screen prevented 
direct contact between the ice (placed in the outer part) and the hand of the subject (placed in the inner 
part). We recorded the time at which the participants considered pain as intolerable. In case the 
participant did not perceive the stimulus as intolerable below two minutes, this value of two minutes 
was considered as tolerance time. We assessed CPM using the cold pressor test as conditioning 
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noxious stimulus and pressure pain tolerance threshold at the 2
nd
 toe as test stimulus (Chitour et al., 
1982; Dubner and Ren, 1999; Danneels et al., 2000; Suzuki et al., 2004; Pud et al., 2009). Thus after 
two minutes of hand immersion in the ice water we again measured pressure pain detection threshold 
and considered the difference in pressure pain detection threshold (after – before cold pressor test) as 
value for CPM. An increase of the threshold while applying the conditioning stimulus indicated 
efficient endogenous pain inhibitory processes.  
 
Baseline and follow-up assessment 
The evaluation of socio-demographic characteristics included age, gender, education (higher vs lower 
education), civil status (married vs not married), living status (living alone vs not living alone), 
working conditions (regular work including housewives vs no regular work), current sick leave 
because of back pain (yes vs no), physical and psychological stress at work (high vs low), and Swiss 
nationality (yes vs no). Patients with at least high school degree were considered as having higher 
education. We defined high work related physical or psychological stress as stress of at least 5 on a 
NRS ranging from 0 “no stress” and 10 “worst stress imaginable”. We characterized the degree of 
depression, anxiety and catastrophizing using the Beck Depression Inventory version 2 (BDI-ll) 
(Morley et al., 2002), the State-Trait-Anxiety-Inventory (STAI) (Laux et al., 1981) and the 
Catastrophizing Scale of the Coping Strategies Questionnaire (CSQ) (Keefe et al., 1989), respectively. 
The clinical assessment included Body-Mass-Index (BMI) with overweight defined as BMI  ≥ 
25kg/m
2
, pain localisation (back pain with irradiation to leg vs local low back pain), pain duration, 
pain intensity, disability, intake of pain medication (yes vs no) and intake of muscle relaxants (yes vs 
no) at baseline. We used the Roland-Morris-Questionnaire (RMQ) to score disability on a scale from 
0 “no disability” to 24 “maximum disability” (Roland and Morris, 1983). We considered non-steroidal 
anti-inflammatory drugs, acetaminophen, metamizole and opioids as pain medication. We chose these 
socio-demographic, psychological and clinical variables because of their documented prognostic 
value for transition to CLBP in previous cohort studies (Dionne et al., 1997; Schiottz-Christensen et 
al., 1999; Coste et al., 2004; Dunn et al., 2006; Jones et al., 2006; Swinkels-Meewisse et al., 2006; 
Foster et al., 2008; Dunn et al., 2011; Campbell et al., 2013). We pre-specified to dichotomize 
education, civil status, living status, working conditions, physical and psychological stress at work 
and BMI to facilitate a clinically meaningful interpretation. To ensure comparability of regression 
coefficients for continuous and binary covariates, we expressed the effect for depression, anxiety, 
catastrophizing, pain intensity and disability as per 2 standard deviation increase (Gelman, 2008). 
We performed telephone interviews six months after the baseline assessment to determine the 
pre-specified primary outcome of transition to CLBP, defined as the presence of low back pain on 
most days during the four weeks preceding the follow-up interview (Airaksinen et al., 2006; Dionne et 
al., 2008). We asked all participants the question “Did you suffer from low back pain at most days of 
the week during the last four weeks?”  
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Statistical analysis 
Assuming a transition to CLBP of 30% at 6 months (Cassidy et al., 2005; Hancock et al., 2007) and a 
standard deviation of 180 kPa for pressure pain tolerance threshold at the second toe (the pre-specified 
primary prognostic variable) (Neziri et al., 2011b), a sample size of 140 patients provided more than 
80% power to detect a minimally clinically relevant difference in pressure pain tolerance thresholds of 
100 kPa between patients with and without transition to CLBP, at a two-sided alpha level of 0.05. A 
sample size of 140 with 42 patients developing chronic low back pain after 6 months will allow the 
inclusion of approximately nine variables in a multivariable model (Vittinghoff and McCulloch, 
2007). 
To determine the predictive ability of different quantitative sensory tests, we estimated odds 
ratios (ORs) for the transition to CLBP from logistic regression and areas under the receiver operating 
characteristics curve (ROC) from a non-parametric model based on multiple imputations for tests with 
missing data (electrical stimulation, temperature stimulation at the arm, cold pressor test, CPM) 
(Rubin, 1976; Harel and Zhou, 2007; Kenward and Carpenter, 2007; Sterne et al., 2009; Spratt et al., 
2010; White et al., 2011). We imputed test data using chained equations with predictive mean 
matching and linear regression generating 15 multiply imputed datasets. As pre-specified, we 
dichotomized education, working and living conditions, civil status, BMI and low back pain with 
radiation to the leg to facilitate a clinically meaningful interpretation. We dichotomized physical and 
psychological stress at work post-hoc because these variables were neither normally nor log-normally 
distributed. Quantitative sensory test data with electrical or pressure stimulation were normally or log-
normally distributed. Heat and cold pain detection thresholds and hand withdrawal time of the cold 
pressor test were truncated and neither normally nor log-normally distributed. Therefore, we 
dichotomized these variables post-hoc using the maximally attainable stimulus as cut-off. To ensure 
comparability of regression coefficients for continuous and binary covariates, we expressed the effect 
for all continuous variables per 2 standard deviations change on the normal or logarithmic scale 
(Gelman, 2008). For continuous socio-demographic, psychological and clinical variables, the effect 
was expressed per 2 standard deviations increase. For continuous quantitative sensory tests, it was 
expressed per 2 standard deviations decrease. For all test variables, ORs above one imply that 
pathological test values (i.e. lower thresholds after pressure, electrical and heat stimulation, higher 
thresholds after cold stimulation, shorter hand withdrawal time of the cold pressor test and impaired 
CPM) are associated with an increased risk of transition to CLBP.  
In our main analysis, we determined crude ORs from univariable models and adjusted ORs 
from multivariable analyses adjusting for socio-demographic, psychological and clinical baseline 
characteristics that were associated with transition to CLBP at a p-value of ≤0.20 in univariable 
analyses, forcing age and gender into the model. We then estimated the area under the ROC curves 
and pre-specified an area of more than 0.70 as clinically relevant. For the two top ranked tests in both 
crude and adjusted analyses, we also calculated sensitivities, specificities, positive and negative 
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likelihood ratios (LR) for different cut-offs, in order to identify potential cut-offs associated with a 
clinically relevant power to rule in or out transition from acute to CLBP. A test was considered to 
provide clinically relevant power to rule in or out transition to CLBP if the positive and negative LRs 
were above 5 or below 0.2, respectively (Jaeschke et al., 1994; Mallett et al., 2012). We performed 
two sets of sensitivity analyses including the same set of co-variates as in main analyses. First, we 
stratified uni- and multivariable logistic regression models by assessor. Second, we estimated 
associations between quantitative sensory tests and pain intensity at 6 months as continuous outcome 
in uni- and multivariable linear regression. All reported p-values are two-sided; all confidence 
intervals refer to 95% boundaries. Analyses were performed with Stata (Version 12.1, StataCorp, 
College Station, TX). 
 
RESULTS 
Study flow and completeness of data 
We screened 551 patients between 2009 and 2015 who presented with acute low back pain and 
included 132 patients (Figure 1). Time and resource constraints led us to close the study 10 patients 
short of the planned number of 140 patients. 82 patients (15%) were ineligible because they suffered 
from chronic pain as defined above, 65 patients (12%) because they suffered from neurologic or 
psychiatric co-morbidities, and 57 patients (10%) because their pain intensity at the time of screening 
was less than NRS 3. Of 279 eligible patients, 15 could not be located (5%) and 132 refused study 
participation (47%). Patients refusing study participation did not differ in terms of age and gender 
from those included in the study (data not presented). Telephone follow-up was complete for 130 
patients (98%). Thirty-two of them had developed CLBP (25%). Data on pressure stimulation as well 
as heat and cold pain detection threshold at the leg were complete. Due to logistic reasons, data on 
heat and cold pain detection threshold at the arm were missing in 9 patients (7%), data on hand 
withdrawal time of the cold pressor test in 4 patients (3%) and data on CPM in 16 patients (12%). 
Data on pain detection and reflex threshold after single electrical stimulation and pain detection after 
repeated electrical stimulation were missing in 18 patients (14%) who were randomly assigned to 
receive an EEG after electrical stimulation rather than an assessment of pain detection and reflex 
thresholds. Additionally, we were unable to evoke a NWR in other 42 patients, since painful 
stimulation became intolerable before a reflex was evoked. Therefore, data of 60 patients were 
missing on this test (46%). We were already confronted with this issue in previous studies (Curatolo 
et al., 2015). In view of the large percentage of missing data and the likely violation of assumptions of 
multiple imputation in patients without evocable reflex, we refrained from analyzing these data.  
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Characterizing the study population  
The study population comprised 71 (55 %) men. Mean age of the total study population was 43.2 
years (SD 13.3, range 20 to 78). Mean depression, anxiety and catastrophizing scores were 6.8 (SD 
6.5, range 0 to 37), 48.7 (SD 11.2, range 23 to 80) and 1.1 (SD 0.9, range 0 to 4), respectively. Fifty-
one (46 %) of all patients were on sick leave because of low back pain. Thirty-six (28 %) of all 
patients had low back pain radiating to the leg. Mean pain duration was 2.1 weeks (SD 1.4, range 4 
days to 6 weeks). Mean baseline values of average, maximum and minimum pain during the last 24h 
in all patients was 4.0 (SD 1.8), 5.7 (SD 2.1) and 2.1 (SD 1.7), respectively. Patients reported a mean 
Roland-Morris disability score of 9.7 (SD 5.5). The majority of the patients took pain medication at 
baseline (N 74, 57%). 
 
Sociodemographic, psychological and clinical predictors for transition to chronic low back pain 
Table 1 presents socio-demographic, psychological and clinical baseline characteristics, and their 
association with transition to CLBP pain after six months. Socio-demographic variables were 
similarly distributed in both patient groups. There were numerically more males among patients with 
transition to CLBP (p=0.30) but mean age (p=0.86) was the same in both groups. We found higher 
scores of depression, anxiety and catastrophizing in patients with transition to CLBP, however only 
anxiety and catastrophizing showed associations at p ≤ 0.20. There were more patients with pain 
radiating to the leg, high pain and high disability among patients with transition to CLBP. Conversely, 
there were fewer patients with overweight and fewer patients taking pain medication at baseline 
among patients with transition to CLBP. Anxiety, catastrophizing, pain intensity, disability and intake 
of pain medication were included into the multivariable model because they showed associations at p 
≤ 0.20. Age and gender were forced into the multivariable analysis irrespective of their p-value. We 
did not find any significant association for gender (OR 1.50, 95% CI 0.63 to 3.56, p=0.36), age (OR 
0.88, 95% CI 0.35 to 2.22, p=0.78), anxiety (OR 1.40, 95% CI 0.49 to 4.06, p=0.53), catastrophizing 
(OR 1.24, 95% CI 0.42 to 3.60, p=0.70), intake of pain medication (OR 0.39 95% CI 0.15 to 1.02, 
p=0.06), baseline pain intensity (OR 1.69, 95% CI 0.62 to 4.66, p=0.31) and baseline disability (OR 
1.83, 95% CI 0.63 to 5.30, p=0.26) in multivariable analysis.  
 
Quantitative sensory tests as predictors for transition to chronic low back pain and pain 
intensity after 6 months 
Table 2 presents crude and adjusted ORs for the associations of the 14 evaluated tests with transition 
to CLBP. For the primary prognostic variable, pressure pain tolerance threshold at the second toe, we 
found no association with transition to CLBP (crude OR 0.99, 95% CI 0.44 to 2.21, adjusted OR 0.76, 
95% CI 0.29 to 1.78). In crude analyses, all estimates appeared randomly scattered around the null, 
with ORs for 10 tests below one and therefore opposite to expectation, and another four above one, 
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concordant with expectation. None of the association was statistically significant. The strongest 
associations in the expected direction, even though non-significant, were found for pain detection 
threshold after single and repeated electrical stimulation, with ORs of 2.00 (95% CI 0.73 to 5.48, 
p=0.17) and 1.67 (95% CI 0.63 to 4.43, p=0.30), respectively. In adjusted analyses, results were much 
the same. Except for pressure pain tolerance threshold at a non-painful site of the low back, 95% 
confidence intervals of all associations included one as measure of no association. Again, we found 
strongest associations for pain detection threshold after single and repeated electrical stimulation, with 
ORs of 2.13 (95% CI 0.68 to 6.65, p=0.19) and 1.73 (95% CI 0.54 to 5.51, p=0.35), respectively. 
Table 3 presents areas under the ROC curves with corresponding 95% Cis. Figure 2 shows the 
ROC curves for the two tests with strongest associations, i.e. pain detection threshold after single and 
repeated electrical stimulation. 95% CIs of all areas under the ROC excluded a clinically relevant 
estimate of more than 0.70. Table 4 presents sensitivities, specificities and LRs for different cut-offs 
for the two top ranked tests, i.e. pain detection after single and repeated electrical stimulation. We did 
not find clinically relevant LRs for any of the cut-offs.  
Table S1 and Table S2 (both web appendix) show the results of sensitivity analyses from uni- 
and multivariable logistic regression models stratified by assessor (Table S1) and uni- and 
multivariable linear regression models using pain intensity after six months as continuous outcome 
(Table S2). Again, we found none of the tests to be associated with transition to CLBP or with pain 
intensity at 6 months.  
 
DISCUSSION 
 
Main findings 
In this prospective cohort study in 130 patients, none of 14 tests evaluating six stimulation modalities 
showed a clinically relevant ability to predict the transition from acute to chronic low back pain. 95% 
confidence intervals of crude and adjusted associations of all tests with CLBP included one as 
measure of no association. None of the 95% confidence intervals of the areas under the ROC crossed 
the pre-specified boundary of clinical relevance set at 0.70. Pain detection after single and repeated 
electrical stimulation were the two most promising tests, with odds ratios around two in both crude 
and adjusted analyses and ROC of 0.58 and 0.57, respectively. However, in further analyses we were 
unable to identify cut-offs that yielded clinically relevant positive or negative likelihood ratios. The 
negative conclusion of our study remained robust to both sensitivity analyses.  
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Strengths and limitations 
To our knowledge, this large cohort study is the first to prospectively assess the ability of 14 
different tests evaluating six modalities to predict transition from acute to CLBP in a primary care 
setting, using ROC and associated parameters of clinical usefulness of diagnostic tests. A major 
strength is the near complete follow-up after six months. The definition of transition to CLBP 
followed established concepts (Airaksinen et al., 2006; Dionne et al., 2008) and the incidence of 
CLBP of 30% is concordant with previous results (Andersson, 1999; Hestbaek et al., 2003; Henschke 
et al., 2008; Chou and Shekelle, 2010; LeResche et al., 2013), which suggests generalizability. Still, it 
may have been useful to include a chronicity grading scale (Gerbershagen et al., 2010). We recruited 
all study participants in a primary care group practice, the main entry point of care for patients with 
acute low back pain.  
A limitation was the difficulty in recruiting the necessary number of patients in this setting, 
which is reflected by a six-year recruitment period. The main reason for this was that many people 
seeking primary care for low back pain suffered from recurrent or chronic low back pain and thus 
were not screened. Time and resource constraints led us to close the study 10 patients short of the 
planned number of 140 patients. This resulted in decreased statistical precision. However, none of the 
95% confidence intervals of areas under the ROC crossed the pre-specified boundary of clinical 
relevance set at larger than 0.70, and none of the tests was associated with pain intensity at 6 months. 
This suggests that the negative conclusion are not merely due to the number of included patients being 
less of than the planned sample size. While modelling associations between tests and pain intensity as 
continuous outcome may result in less readily available clinical interpretation, it increases the 
statistical precision required to detect associations between tests and transition to CLBP.  
The calculation of ROC and associated parameters such as sensitivity, specificity and 
likelihood ratios is a major strength, as these parameters are the main elements to evaluate the clinical 
usefulness of a diagnostic test. Another limitation was that QST was performed by four different 
assessors. However, all assessors performed the QST according to a previously applied and 
standardized protocol (Neziri et al., 2012), and sensitivity analyses stratified by assessor yielded much 
the same conclusions as the main analyses. Assessors were specialized study nurses and medical 
doctors working in the laboratory of the Pain Clinic, Bern University Hospital. They were trained by 
M.C. and A.N., who had performed hundreds of tests in previous studies.  
An important strength of our study is the large number of tests that represent different 
dimensions of nociception and pain experience (Neziri et al., 2011a). However, we did not include 
other potentially relevant tests such as vibration detection threshold, dynamic mechanical allodynia 
and pinprick hyperalgesia (Maier et al., 2010). The reasons were two-fold. First, we based the 
selection on a validated protocol applied in our previous research (Neziri et al., 2011a; Neziri et al., 
2012). Second, our protocol took 120 minutes per patient to be completed. We found it difficult to 
further expand it, also considering that we tested pain patients rather than healthy individuals. Another 
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strength is that less than 10% of data were missing for covariates and  tests, except for pain and reflex 
thresholds after electrical stimulation.  
 
Context 
After initiation of this cohort study, we performed a case-control study and ranked 26 
quantitative sensory tests according to their ability to discriminate CLBP patients and pain-free 
controls (Neziri et al., 2012). The six tests that ranked highest were pressure pain detection threshold 
at the site of most severe low back pain, pain detection threshold after single electrical stimulation, 
reflex threshold after single electrical stimulation, pressure pain tolerance threshold at the site of most 
severe low back pain, pressure pain detection threshold at the supra-scapular region, and temporal 
summation pain detection threshold. All these tests displayed an excellent discrimination reflected by 
areas under the ROC of 0.80 or more. In the present study, we report results for all of these tests, 
except for the third (reflex detection threshold) and the fifth ranked tests (pressure pain detection 
threshold at the supra-scapular region). We found none of them to display clinically relevant 
predictive ability and thus could not confirm the findings of our previous case-control study. The 
difference in results between the current cohort and the previous case-control study is likely to be 
explained by the study designs per se. Results of the case-control study were based on a cross-
sectional, arbitrary contrast between clearly symptomatic cases with long-lasting pain referred to a 
tertiary-care center and absolutely asymptomatic controls (Lachs et al., 1992; Rutjes et al., 2005; 
Neziri et al., 2012). Conversely, patients of this cohort study were recruited at the time of developing 
acute low back pain and prospectively followed up to determine their clinical course. Therefore, a 
decrease in performance of the tests in the current study in a primary care setting was expected (Neziri 
et al., 2012). However, the decrease in performance of the top ranked or any other tests was extensive, 
since none of them showed a clinically relevant ability to predict transition from acute to CLBP.  
Our results are in line with the findings of a previously published prospective cohort study of 
similar design, which assessed the prognostic performance of five quantitative sensory tests in 
patients with acute low back pain (LeResche et al., 2013) and a recently published systematic review 
evaluating the prognostic value of QST in low back pain (Marcuzzi et al., 2016). The systematic 
review found only three studies investigating the prognostic value of QST in acute or CLBP. None of 
the studies found an association between quantitative sensory tests and low back pain outcomes, 
which supports our findings (Marcuzzi et al., 2016). The present study also confirms the lacking 
prognostic performance of two of the five tests examined in the cohort of LeResche et al and adds 
evidence for the lacking performance of an additional 11 tests. LeResche et al discussed the limited 
statistical precision as a potential alternative explanation of their negative results. In our study, 95% 
CIs of the estimated areas under the ROC were all below 0.70, which makes a clinically relevant 
predictive ability of any test unlikely.  
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Paradoxically, the majority of the ROCs were below 0.50, suggesting that less central 
hypersensitivity would be associated with increased risk of transition to CLBP. However, there is no 
pathophysiological support for this result and all upper limits of 95% confidence intervals were above 
0.50, which would be compatible with our hypothesis that more pathological test values are associated 
with CLBP.  
Pain detection thresholds after single and repeated electrical stimulation displayed odds ratios 
around two in both crude and adjusted analyses. This finding suggests that pain hypersensitivity as 
detected by electrical stimulation may have a pathophysiological association with the development of 
CLBP. However, the present study aimed at testing the clinical usefulness of QST in predicting the 
transition from acute to chronic pain. For this purpose, the values of odds ratios or the level of 
statistical significance are not of primary importance. Rather, sensitivity, specificity and likelihood 
ratios have to reach levels that make the tests useful for clinical decision in individual patients. In 
further analyses of these two electrical pain tests, we did not find clinically relevant positive or 
negative likelihood ratios that could be used to identify patients at high or low risk of CLBP.  
 
Implications for future research 
Our findings do not necessarily imply that central hypersensitivity is not involved in transition 
to chronic pain, but may reflect the limited ability of current quantitative sensory tests to detect 
clinically relevant central pain processes. Future research should aim at identifying biomarkers of 
central hypersensitivity that are better linked to patient-relevant outcomes. Studies should investigate 
the predictive value of a combination of different tests that are likely to represent different dimensions 
of nociception. Assessment methods based on the NWR as involuntary response to nociceptive 
stimulation are able to determine central hypersensitivity more objectively than traditional tests 
(Banic et al., 2004; Sterling, 2010; Neziri et al., 2012). Therefore, further technical and 
methodological improvement of this test and the investigation of reasons for the inability to elicit an 
NWR would be important.  
 
Conclusions 
We found no evidence for a clinically relevant ability of QST to predict the transition from 
acute to CLBP. This indicates that assessment of central hypersensitivity using currently available 
quantitative sensory tests is unlikely to identify patients at risk and therefore unlikely to inform 
clinical decision making.  
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LEGENDS OF FIGURES  
Figure 1: Study flow chart.  
Legend: 
*defined as pain <6 weeks and/or <3 episodes per year 
°NRS: Numerical Rating Scale from 0 (no pain) to 10 (maximum pain) 
$other included: 2 doctor denied contact with patient, 8 unclear, 8 language problems, 9 pregnancy 
Figure 2: Receiver operating characteristic (ROC) curves showing the area under the curve (solid line) 
for pain detection threshold after single electrical stimulation (solid line) and pain detection threshold 
after repeated electrical stimulation (dashed line).  
Legend:  
Diagonal line represents a hypothetical ROC curve that yielded no discriminative information. 
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Table 1: Baseline characteristics in patients with and without transition to chronic low back pain after 
six months. Values are numbers (percentage), means (standard deviation), unadjusted odds ratios 
(OR) with corresponding 95% confidence intervals (95% CI), and p-values from univariable logistic 
regression models.  
 Transition to chronic low back pain   
 Yes (N=32) No (N=98) Crude OR (95% CI) p-value 
Socio-demographic characteristics     
Males  20 (63%) 51 (52%) 1.54 (0.68, 3.48) 0.30 
Age (years) d 43.5 (13.6) 43.1 (13.3) 1.07 (0.48, 2.43) 0.86 
Higher education  17 (53%) 51 (52%) 1.04 (0.47, 2.32) 0.92 
Married  12 (38%) 35 (36%) 1.08 (0.47, 2.47) 0.86 
Living alone  10 (31%) 30 (31%) 1.03 (0.44, 2.44) 0.95 
Regular work a 26 (81%) 81 (83%) 0.91 (0.32, 2.55) 0.86 
Sick leave because of back pain 12 (38%) 39 (40%) 0.91 (0.40, 2.07) 0.82 
High physical stress at work b  11 (34%) 35 (36%) 0.94 (0.41, 2.18) 0.89 
High psychological stress at work b  19 (59%) 56 (57%) 1.10 (0.49, 2.47) 0.82 
Psychological characteristics     
Depression (BDI-ll) e 8.5 (9.0) 6.2 (5.5) 1.45 (0.64, 3.27) 0.37 
Anxiety (STAI Trait) d 51.8 (14.0) 47.6 (9.9) 2.13 (0.95, 4.81) 0.07 
Catastrophizing (CSQ) d 1.3 (0.97) 1.0 (0.81) 2.18 (1.00, 4.74) 0.05 
Clinical characteristics     
Overweight (BMI cut-off ≥25kg/m2)  12 (38%) 38 (39%) 0.95 (0.42, 2.16) 0.90 
Low back pain with irradiation to leg  11 (34%) 25 (26%) 1.53 (0.65, 3.61) 0.33 
Pain duration (weeks) d 1.8 (0.9) 2.2 (1.5) 0.53 (0.18, 1.61) 0.27 
Pain intensity at baseline d  4.4 (2.0) 3.8 (2.8) 1.98 (0.87, 4.51) 0.10 
Disability at baseline (RMQ) d 11.0 (5.5) 9.3 (5.4) 1.80 (0.82, 3.97) 0.15 
Intake of pain medication c  15 (47%) 59 (60%) 0.58 (0.26, 1.30) 0.19 
Intake of muscle relaxant 7 (22%) 22 (22%) 0.97 (0.37, 2.53) 0.95 
a includes houseworkers 
b high stress and high pain defined as at least 5 on a numerical rating scale from 0 (no pain/stress) to 10 (maximum pain/stress) 
c includes non-steroidal anti-inflammatory drugs, acetaminophen, metamizole, opioids 
d OR per two standard deviation increase 
e 
OR per two log-standard deviation increase  
OR>1.0 means increased risk for transition to chronic low back pain 
 
BDI-ll: Beck Depression Inventory Version 2  
STAI Trait: State Trait Anxiety Index t-value  
CSQ: Catastrophizing Scale of Coping Strategies Questionnaire  
RMQ: Roland Morris Questionnaire 
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Table 2: Results of 14 quantitative sensory tests at baseline in patients with and without transition to chronic low 
back pain after six months. Values are mean (standard deviation), numbers (percentages), odds ratios (OR) with 
corresponding 95% confidence intervals (95% CI), and p-values from uni- and multivariable logistic regression 
models.  
 
Transition to chronic low 
back pain 
    
 
Yes 
(N=32) 
No (N=98) 
Crude OR  
(95% CI) 
p-
value 
Adjusted OR 
(95% CI) 
p-
value 
Pressure pain (kPa)       
detection threshold, 2nd toe b 273 (148) 267 (93) 0.83 (0.37, 
1.86) 
0.66 0.68 (0.28, 
1.64) 
0.39 
tolerance threshold, 2nd toe b 469 (140) 485 (193) 0.99 (0.44, 
2.21) 
0.98 0.76 (0.29, 
1.98) 
0.57 
detection threshold, most painful site at 
back c 
378 (217) 342 (223) 0.73 (0.33, 
1.57) 
0.42 0.62 (0.25, 
1.56) 
0.31 
tolerance threshold, most painful site at 
back c 
621 (260) 607 (278) 0.90 (0.40, 
2.02) 
0.80 0.61 (0.22, 
1.69) 
0.34 
detection threshold, non-painful site at 
back c 
494 (213) 440 (229) 0.62 (0.28, 
1.37) 
0.24 0.51 (0.20, 
1.30) 
0.16 
tolerance threshold, non-painful site at 
back c 
797 (175) 706 (237) 0.41 (0.17, 
1.00) 
0.05 0.24 (0.08, 
0.72) 
0.01 
Electrical pain (mA)   
    
detection threshold, single stimulation a, 
c 
7.0 (3.6) 8.0 (3.8) 2.10 (0.67, 
6.42) 
0.20 2.20 (0.62, 
7.86) 
0.22 
detection threshold, repeated stimulation 
a, c 
5.7 (2.7) 6.3 (2.4) 1.95 (0.68, 
5.63) 
0.22 2.11 (0.60, 
7.39) 
0.24 
Heat pain (°C, cut-off < 50.5)   
    
detection threshold, leg   26 (81%) 83 (85%) 0.78 (0.28, 
2.22) 
0.65 0.67 (0.21, 
2.13) 
0.50 
detection threshold, arm a 27 (83%) 82 (84%) 0.89 (0.29, 
2.71) 
0.84 0.77 (0.22, 
2.66) 
0.68 
Cold pain (°C, cut-off >0.0)       
detection threshold, leg 12 (38%) 39 (40%) 0.91 (0.39, 
2.07) 
0.82 0.69 (0.28, 
1.70) 
0.43 
detection threshold, arm a 15 (48%) 59 (60%) 1.64 (0.69, 
3.91) 
0.26 1.24 (0.48, 
3.23) 
0.66 
Cold pressor test (s, cut-off < 120)       
      hand withdrawal time a 28 (88%) 79 (81%) 1.60 (0.50, 
5.12) 
0.43 1.49 (0.45, 
5.00) 
0.52 
Conditioned pain modulation (CPM)       
      % of patients without increase in 
pressure pain    
      tolerance threshold at 2nd toe a 
9 (27%) 33 (34%) 0.73 (0.28, 
1.88) 
0.50 0.73 (0.27, 
2.00) 
0.54 
a Results after multiple imputation (electrical pain detection threshold:18 missing values; heat and cold pain detection 
thresholds arm: 9 missing values; cold pressor test: 4 missing values; CPM: 16 missing values) 
Adjusted OR included age, gender, anxiety, catastrophizing, pain intensity, disability and intake of pain medication at 
baseline  
b OR per two log-standard deviation decrease 
c OR per two standard deviation decrease 
OR>1.0 means pathological values of quantitative sensory tests are associated with increased risk for transition to chronic 
low back pain (i.e. lower thresholds after pressure, electrical and heat stimulation, higher thresholds after cold stimulation, 
shorter hand withdrawal time and impaired CPM) 
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Table 3: Area under the ROC curves (AUC) with corresponding 95% confidence intervals for 
different quantitative sensory tests. 
 Crude AUC (95% CI) 
Pressure pain   
detection threshold, 2nd toe 0.46 (0.35, 0.56) 
tolerance threshold, 2nd toe 0.51 (0.40, 0.62)  
detection threshold, site most pain back 0.43 (0.32, 0.55) 
tolerance threshold, site most pain back 0.49 (0.38, 0.60) 
detection threshold, site no pain back 0.42 (0.30, 0.53) 
tolerance threshold, site no pain back 0.38 (0.28, 0.48) 
Electrical pain   
detection threshold, single stimulation a 0.58 (0.47, 0.70) 
detection threshold, repeated stimulation a 0.57 (0.46, 0.69) 
Heat pain   
detection threshold, leg   0.43 (0.32, 0.54) 
detection threshold, arm a  0.37 (0.27, 0.47) 
Cold pain   
detection threshold, leg  0.50 (0.40, 0.61) 
detection threshold, arm a 0.60 (0.48, 0.71) 
Cold pressor test   
      Hand withdrawal time a 0.58 (0.47, 0.69) 
Conditioned pain modulation   
      difference pressure pain detection threshold, 2nd toe a 0.47 (0.35, 0.59) 
a AUC based on predicted value after multiple imputation  
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Table 4: Diagnostic accuracy of electrical pain detection threshold after single and repeated electrical stimulation according to different cut-off values. Values 
presented are point estimates with corresponding 95% confidence intervals.  
 No. patients 
 
  
 
Likelihood Ratio  
Cut-off value, mA a TP FN FP TN 
 
Sensitivity, % 
(95% CI) 
Specificity, % 
(95% CI) 
 
Positive Negative 
Electrical pain detection threshold single stimulation 
5 5 27 10 88  15.6 (5.3, 32.8) 89.8 (82.0, 95.0)  1.53 0.94 
6 12 20 26 72  37.5 (21.1, 56.3) 73.4 (63.6, 81.9)  1.41 0.85 
7 19 13 49 49  59.4 (40.6, 76.3) 50.0 (39.7, 60.2)  1.19 0.81 
8 21 11 57 41  65.6 (46.8, 81.4) 41.8 (32.0, 52.2)  1.13 0.82 
9 25 7 68 30  78.1 (60.0, 90.7) 30.6 (21.7, 40.7)  1.13 0.72 
10 28 4 76 22  87.5 (71.0, 96.5) 22.4 (14.6, 32.0)  1.13 0.56 
Electrical pain detection threshold repeated stimulation 
4 4 28 8 90  12.5 (3.5, 29.0) 91.8 (84.5, 96.4)  1.52 0.95 
5 9 23 17 81  28.1 (13.8, 46.8) 82.7 (73.7, 89.6)  1.62 0.87 
6 17 15 40 58  53.1 (34.7, 70.9) 59.1 (48.8, 69.0)  1.30 0.79 
7 24 8 69 29  75.0 (56.6, 88.5) 29.6 (20.8, 39.7)  1.07 0.84 
8 27 5 74 24  84.4 (67.2, 94.7) 24.5 (16.4, 34.2)  1.12 0.64 
9 30 2 87 11  93.8 (79.2, 99.2) 11.2 (5.7, 19.2)  1.06 0.55 
Values are point estimates with corresponding 95% confidence intervals after predicting missing values based on multiple imputation 
a cut-off: below cut-off was considered as test positive; equal or above cut-off was considered as test negative 
TP: true positive, FN: false negative, FP: false positive, TN: true negative 
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